“Due to the Company’s strong financial backing
Post# of 72430
I take it the further progress in our clinical trials is somewhere between good and out-of-this-world fantastic. Anything less would make an intention to up-list unfounded. Sounds good to me!
![](/images/icons/icon_smile.gif)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)